Home › Funds › ProShares › Small-Cap Growth Profund
Fund family: ProShares · Filed by ProFunds (CIK 1039803) · SEC series S000003060
Share classes and tickers: SGPIX (C000008336), SGPSX (C000008337)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 2,874 with, 15 against, 0 abstentions (not counted as with management). Shareholder proposals: 11 FOR, 2 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as ProShares’s manager page (303,945 ballot items across 135 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | ProShares | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 91.9% | 2,817 | 91.4% | 279,029 |
| Backed environmental and social shareholder proposals at US companies | n/a | 1 | 10.6% | 4,043 |
Each ballot item this fund voted is set against the votes of the other ProShares funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted the same way as most ProShares funds on all 2,792 items where a comparison was possible.
The same votes as “with management” above, by the sector of the company voted on. 97.6% of this fund’s 2,889 such votes could be given a sector; the other 70 (2.4%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Finance | 547 | 1 | 0.2% |
| Consumer Discretionary | 544 | 7 | 1.3% |
| Health Care | 404 | 4 | 1.0% |
| Industrials | 370 | 1 | 0.3% |
| Technology | 356 | 1 | 0.3% |
| Real Estate | 243 | 0 | 0.0% |
| Utilities | 106 | 0 | 0.0% |
| Energy | 84 | 0 | 0.0% |
| Consumer Staples | 67 | 0 | 0.0% |
| Telecommunications | 53 | 1 | 1.9% |
| Miscellaneous | 42 | 0 | 0.0% |
| Basic Materials | 3 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 2,042 | 5 |
| Say-on-Pay | 355 | 0 |
| Audit-related | 320 | 0 |
| Compensation | 99 | 0 |
| Corporate Governance | 58 | 8 |
| Extraordinary Transactions | 23 | 0 |
| Capital Structure | 12 | 0 |
| Shareholder Rights and Defenses | 8 | 1 |
| Human Rights or Human Capital/workforce | 1 | 1 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| TG Therapeutics, Inc. | June 11, 2026 | $82,404 | 8 | 0 |
| Armstrong World Industries, Inc. | June 11, 2026 | $72,157 | 12 | 0 |
| Ligand Pharmaceuticals Incorporated | June 5, 2026 | $56,420 | 11 | 0 |
| CSW Industrials, Inc. | August 28, 2025 | $55,380 | 10 | 0 |
| Protagonist Therapeutics, Inc. | June 17, 2026 | $54,551 | 5 | 0 |
| Brinker International, Inc. | November 20, 2025 | $51,066 | 12 | 0 |
| Clear Secure, Inc. | June 10, 2026 | $47,809 | 13 | 0 |
| Glaukos Corporation | May 28, 2026 | $45,549 | 4 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| June 9, 2026 | Etsy, Inc. | Advisory vote on a stockholder proposal to govern by majority vote. Shareholder proposal | Against | For |
| March 9, 2026 | Sanmina Corporation | To consider and vote upon the stockholder proposal entitled "Independent Board Chairman," requesting that the Board of Directors adopt a policy and amend governing documents as necessary in order that two separate people hold the office of the Chairman and the office of the CEO. Shareholder proposal | Against | For |
| June 10, 2026 | MarketAxess Holdings Inc. | If properly presented, a stockholder proposal regarding changes to existing stockholder special meeting right. Shareholder proposal | For | Against |
| June 9, 2026 | Pacira Biosciences, Inc. | Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Company Nominees: DOMA Nominees Opposed by the Company: Oliver Benton Curtis III Shareholder proposal | Withhold | For |
| June 9, 2026 | Pacira Biosciences, Inc. | Election of three Class III directors to our board of directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Company Nominees: DOMA Nominees Opposed by the Company: Eric de Armas Shareholder proposal | Withhold | For |
| May 13, 2026 | ICU Medical, Inc. | To approve, on an advisory basis, a stockholder proposal to establish a 10% stockholder special meeting right. Shareholder proposal | For | Against |
| May 5, 2026 | SkyWest, Inc. | A shareholder proposal regarding collective bargaining policy. Shareholder proposal | For | Against |
| May 14, 2026 | Calix, Inc. | To hold an advisory vote on a stockholder proposal relating to a simple majority vote. Shareholder proposal | For | Against |
| December 15, 2025 | UniFirst Corporation | To elect two Class II directors, each to serve for a term of three years until the 2029 annual meeting of shareholders and until their respective successors are duly elected and qualified: Arnaud Ajdler Shareholder proposal | For | Against |
| December 15, 2025 | UniFirst Corporation | To elect two Class II directors, each to serve for a term of three years until the 2029 annual meeting of shareholders and until their respective successors are duly elected and qualified: Michael A. Croatti Shareholder proposal | For | Against |
| May 20, 2026 | Lumen Technologies, Inc. | Approval of a shareholder proposal regarding a shareholder right to vote for or against a poison pill. Shareholder proposal | For | Against |
| June 3, 2026 | Resideo Technologies, Inc. | Shareholder Proposal Regarding Shareholder Right to Act by Written Consent. Shareholder proposal | For | Against |
Meetings with a proxy contest or competing nominees (2 in 2025-2026), and how the fund voted the items on its ballot.
These funds reported the same votes as Small-Cap Growth Profund in the latest season, so they share this page:
2,918 ballot items at 341 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Small-Cap Growth Profund (SGPIX) voted at 341 shareholder meetings of 335 companies, on 2,918 ballot items in all. Where management made a recommendation, the fund followed it on 99.5% of the items and voted against it 15 times. Its most frequent area of disagreement was corporate governance (8 of its votes against management). It voted on 16 shareholder proposals. It voted FOR the board's own proposals more often than ProShares's funds as a whole (91.9% against 91.4%). It voted the same way as most ProShares funds on every item where a comparison was possible. 2 of its meetings were contested.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of ProShares’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.